100
Participants
Start Date
June 30, 2000
Study Completion Date
July 31, 2010
alemtuzumab
anti-thymocyte globulin
filgrastim
rituximab
therapeutic allogeneic lymphocytes
busulfan
cyclophosphamide
cyclosporine
fludarabine phosphate
methotrexate
mycophenolate mofetil
peripheral blood stem cell transplantation
radiation therapy
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin
University Hospital Schleswig-Holstein - Kiel Campus, Kiel
Medizinische Hochschule Hannover, Hanover
Universitaetsklinikum Goettingen, Göttingen
Universitaetsklinikum Essen, Essen
Universitaetsklinikum des Saarlandes, Homburg
Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm
Klinikum der Universitaet Regensburg, Regensburg
Maisonneuve-Rosemont Hospital, Montreal
Asklepios Klinik St. Georg, Hamburg
Universitaets-Kinderklinik Heidelberg, Heidelberg
Clinic for Bone Marrow Transplantation and Hematology and Oncology, Idar-Oberstein
University Hospital of Leipzig, Leipzig
German CLL Study Group
OTHER